4//SEC Filing
Karas Eric 4
Accession 0001415889-25-017901
CIK 0001671858other
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 6:38 PM ET
Size
8.6 KB
Accession
0001415889-25-017901
Insider Transaction Report
Form 4
Karas Eric
Chief Commercial Officer
Transactions
- Sale
Common Stock
2025-06-18$16.00/sh−15,000$240,000→ 7,696 total - Exercise/Conversion
Common Stock
2025-06-18$1.50/sh+15,000$22,500→ 22,696 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-06-18−15,000→ 559,588 totalExercise: $1.50Exp: 2032-05-23→ Common Stock (15,000 underlying)
Footnotes (2)
- [F1]The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 26, 2024.
- [F2]Immediately exercisable.
Documents
Issuer
ARS Pharmaceuticals, Inc.
CIK 0001671858
Entity typeother
Related Parties
1- filerCIK 0001951287
Filing Metadata
- Form type
- 4
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 6:38 PM ET
- Size
- 8.6 KB